Autonomic Nervous System Drugs — MCQs
On this page
Drug S is most like which of the following drugs?
The action of non-competitive muscle blockers is affected by which of the following?
The difference between hyoscine and atropine is that hyoscine:
Which mydriatic agent is typically used for fundoscopic examination?
What is the probable diagnosis in a patient with a dilated pupil not responsive to 1% pilocarpine?
Which of the following drugs produces an action on the dilator pupillae that is analogous to the action of pilocarpine on the sphincter pupillae?
Retroperitoneal fibrosis is seen with which 5HT1 and 5HT2 receptor antagonist?
Which toxin increases the exocytosis of acetylcholine-containing vesicles?
Which of the following is the drug of choice for treating anaphylactic shock?
A patient requires mild cholinomimetic stimulation following surgery. Physostigmine and bethanechol in small doses have significantly different effects on which of the following?
Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs
Question 141: Drug S is most like which of the following drugs?
- A. Epinephrine
- B. Isoproterenol (Correct Answer)
- C. Norepinephrine
- D. Phenylephrine
Explanation: ***Isoproterenol*** - Drug S demonstrates high **β1 and β2 adrenergic activity** with negligible **α-adrenergic activity**, which uniquely matches isoproterenol's receptor profile. - Isoproterenol is a **non-selective β-agonist** that produces **positive inotropic** and **chronotropic effects** (β1) along with **bronchodilation** and **vasodilation** (β2). *Epinephrine* - Has significant **α-adrenergic activity** in addition to β-activity, causing **vasoconstriction** at higher doses, unlike Drug S. - Shows a **mixed receptor profile** (α1/α2/β1/β2) with dose-dependent effects, contrasting with Drug S's pure β-selectivity. *Norepinephrine* - Primarily acts on **α1, α2, and β1 receptors** with minimal **β2 activity**, causing predominant **vasoconstriction**. - Lacks the significant **β2-mediated bronchodilation** and **vasodilation** profile seen in Drug S. *Phenylephrine* - Is a **selective α1-agonist** with no significant **β-adrenergic activity**, producing only **vasoconstriction**. - Completely lacks the **β1 and β2 receptor activation** that characterizes Drug S's pharmacological profile.
Question 142: The action of non-competitive muscle blockers is affected by which of the following?
- A. Hypocalcemia (Correct Answer)
- B. Hyponatremia
- C. Hyperthermia
- D. All of the above
Explanation: **Explanation:** Non-competitive (depolarizing) muscle relaxants, such as **Succinylcholine**, act by mimicking acetylcholine at the nicotinic receptors, causing persistent depolarization of the motor endplate. **Why Hypocalcemia is the correct answer:** Calcium plays a critical role in neuromuscular transmission. Low extracellular calcium (**Hypocalcemia**) reduces the release of Acetylcholine (ACh) from the pre-synaptic nerve terminal. Since there is less endogenous ACh to compete for receptors or initiate normal contraction, the muscle becomes more sensitive to the effects of neuromuscular blockers. Clinically, hypocalcemia **potentiates** the blockade, leading to prolonged muscle relaxation and potential respiratory delay. **Analysis of Incorrect Options:** * **Hyponatremia:** While sodium is essential for action potential propagation, minor fluctuations in serum sodium levels do not significantly alter the clinical efficacy or duration of neuromuscular blockers compared to divalent cations like calcium and magnesium. * **Hyperthermia:** Generally, **hypothermia** (not hyperthermia) prolongs the duration of muscle blockers by slowing metabolism (e.g., pseudocholinesterase activity) and delaying organ excretion. Hyperthermia may actually shorten the duration of action for some agents. **High-Yield Clinical Pearls for NEET-PG:** * **Magnesium Interaction:** Hypermagnesemia (often seen in pre-eclampsia treatment) also potentiates neuromuscular blockers by inhibiting ACh release and decreasing post-junctional sensitivity. * **Hypokalemia:** Potentiates **non-depolarizing** blockers (e.g., Vecuronium) but can antagonize/resist **depolarizing** blockers (Succinylcholine). * **Phase II Block:** Succinylcholine can transition from a depolarizing to a non-depolarizing-like block (Phase II) with prolonged infusion or high doses.
Question 143: The difference between hyoscine and atropine is that hyoscine:
- A. Causes less depression of the CNS at relative low doses. (Correct Answer)
- B. Causes more potent effects on the heart than on the eye.
- C. Is longer acting.
- D. Has anti-motion sickness activity.
Explanation: ### Explanation The primary difference between **Hyoscine (Scopolamine)** and **Atropine** lies in their central nervous system (CNS) effects and potency on specific end-organs. Both are tertiary ammonium belladonna alkaloids that act as competitive antagonists at muscarinic receptors. **1. Why Option A is Correct:** At therapeutic doses, **Atropine** is a mild CNS stimulant, primarily affecting the medullary centers. In contrast, **Hyoscine** produces prominent **CNS depression** even at low doses, leading to drowsiness, euphoria, amnesia, and sedation. Therefore, hyoscine causes *more* (not less) depression than atropine. *(Note: There appears to be a typographical error in the provided key/option text. In standard pharmacology, Hyoscine causes **more** CNS depression than Atropine. If Option A is the intended answer, it usually reads "Causes more depression of the CNS.")* **2. Analysis of Incorrect Options:** * **Option B:** Hyoscine is actually **more potent** on the eye (mydriasis/cycloplegia) and secretory glands (salivary/sweat), whereas Atropine has a more significant effect on the **heart** (tachycardia). * **Option C:** Hyoscine has a **shorter duration of action** compared to Atropine. * **Option D:** While Hyoscine *does* have anti-motion sickness activity, this is a **similarity** (both cross the BBB, though Hyoscine is the drug of choice), not the primary pharmacological "difference" usually tested regarding their CNS profiles. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** Hyoscine is the DOC for **Motion Sickness** (administered as a transdermal patch behind the ear). * **Amnesia:** Hyoscine is used in pre-anesthetic medication for its **vestibulocochlear suppression** and **anterograde amnesia**. * **Atropine Flush:** High doses of atropine cause cutaneous vasodilation (Atropine fever). * **Mnemonic for Atropine Poisoning:** "Hot as a hare, blind as a bat, dry as a bone, red as a beet, and mad as a hatter."
Question 144: Which mydriatic agent is typically used for fundoscopic examination?
- A. Homatropine
- B. Phenylephrine
- C. Tropicamide (Correct Answer)
- D. Atropine
Explanation: **Explanation:** **Tropicamide** is the drug of choice for diagnostic fundoscopic examinations because it is the **shortest-acting** antimuscarinic agent. It produces rapid-onset mydriasis (dilation) and cycloplegia (paralysis of accommodation). Its effect peaks within 20–40 minutes and lasts only 4–6 hours, allowing the patient to return to normal visual activities much faster than with other agents. **Analysis of Options:** * **Homatropine (Option A):** A semi-synthetic derivative of atropine with a duration of 1–3 days. It is primarily used in the treatment of anterior uveitis to prevent synechiae, but it is too long-acting for routine fundoscopy. * **Phenylephrine (Option B):** An alpha-1 agonist that causes mydriasis without cycloplegia. While often used as an adjunct to Tropicamide to enhance dilation, it is not the primary agent of choice because it does not provide the necessary cycloplegia for a thorough refractive exam in all patients. * **Atropine (Option C):** The most potent antimuscarinic with the longest duration of action (7–10 days). It is contraindicated for routine fundoscopy due to the prolonged "blurring of vision" and risk of systemic toxicity in children. **High-Yield NEET-PG Pearls:** * **Mnemonic for Duration:** **A**tropine (7 days) > **S**copolamine (3-5 days) > **H**omatropine (1-3 days) > **C**yclopentolate (24 hours) > **T**ropicamide (6 hours). (**A S**hip **H**as **C**ome **T**onight). * **Drug of Choice for Cycloplegic Refraction in Children:** Atropine (ointment preferred) or Cyclopentolate. * **Contraindication:** All mydriatics are contraindicated in patients with a narrow iridocorneal angle (risk of Acute Angle Closure Glaucoma).
Question 145: What is the probable diagnosis in a patient with a dilated pupil not responsive to 1% pilocarpine?
- A. Diabetic 3rd nerve palsy
- B. Adie's tonic pupil
- C. Uncal herniation
- D. Pharmacological block (Correct Answer)
Explanation: This question tests your understanding of the **Pilocarpine Test**, used to differentiate between neurogenic and pharmacological causes of a dilated pupil (mydriasis). ### **Explanation of the Correct Answer** **Pharmacological block** occurs when the muscarinic receptors on the iris sphincter muscle are occupied by an antagonist (e.g., Atropine, Tropicamide). * **Mechanism:** Pilocarpine is a direct-acting muscarinic agonist. If the receptors are physically blocked by an anticholinergic drug, even a high concentration (1%) of pilocarpine cannot bind to the receptors to cause miosis. * **Clinical Rule:** A pupil that fails to constrict with 1% pilocarpine is diagnostic of pharmacological blockade. ### **Why the Other Options are Incorrect** * **A. Diabetic 3rd nerve palsy:** This is a "pupil-sparing" palsy because the parasympathetic fibers are located peripherally on the nerve and are usually spared from ischemic damage. Even if the pupil were involved, it would still respond to 1% pilocarpine because the receptors themselves are functional. * **B. Adie’s tonic pupil:** This is due to post-ganglionic denervation. It exhibits **denervation supersensitivity**, meaning the pupil will constrict even with very dilute (0.125%) pilocarpine, which would not affect a normal pupil. * **C. Uncal herniation:** This causes a 3rd nerve compression (pre-ganglionic lesion). Since the iris sphincter receptors are intact and healthy, the pupil will constrict promptly when 1% pilocarpine is instilled. ### **NEET-PG High-Yield Pearls** 1. **0.125% Pilocarpine:** Used to diagnose **Adie’s Tonic Pupil** (constricts due to supersensitivity). 2. **1% Pilocarpine:** Used to differentiate **3rd Nerve Palsy** (constricts) from **Pharmacological Block** (no constriction). 3. **Aneurysm vs. Diabetes:** A 3rd nerve palsy with pupil involvement (mydriasis) is a surgical emergency, often suggesting a **Posterior Communicating Artery aneurysm** compressing the nerve.
Question 146: Which of the following drugs produces an action on the dilator pupillae that is analogous to the action of pilocarpine on the sphincter pupillae?
- A. Epinephrine (Correct Answer)
- B. Hydroxyamphetamine
- C. Cocaine
- D. Timolol
Explanation: **Explanation:** The core concept of this question lies in distinguishing between **direct-acting** and **indirect-acting** autonomic drugs. **1. Why Epinephrine is Correct:** * **Pilocarpine** is a **direct-acting** cholinergic agonist. It acts directly on the muscarinic receptors of the **sphincter pupillae** muscle to cause miosis. * The question asks for a drug that acts on the **dilator pupillae** in an "analogous" (similar) manner. * **Epinephrine** is a **direct-acting** adrenergic agonist. It acts directly on the alpha-1 receptors of the **dilator pupillae** muscle to cause mydriasis. Both drugs bypass the nerve terminal and act directly on the effector muscle receptors. **2. Why the Other Options are Incorrect:** * **Hydroxyamphetamine (Option B):** This is an **indirect-acting** sympathomimetic. It works by displacing stored norepinephrine from the presynaptic nerve endings. It does not act directly on the muscle receptors. * **Cocaine (Option C):** This is an **indirect-acting** sympathomimetic. It works by inhibiting the reuptake (Uptake-1) of norepinephrine at the synaptic cleft. * **Timolol (Option D):** This is a non-selective **beta-blocker** used to decrease aqueous humor production in glaucoma; it has no significant effect on the pupillary size as the iris muscles are primarily controlled by alpha and muscarinic receptors. **Clinical Pearls for NEET-PG:** * **Direct vs. Indirect:** In Horner’s Syndrome, a direct-acting agonist (like Phenylephrine) will cause pupillary dilation regardless of the lesion site, whereas an indirect-acting agent (like Cocaine or Hydroxyamphetamine) requires an intact post-ganglionic neuron to function. * **Pilocarpine** is the drug of choice for the emergency treatment of Acute Angle Closure Glaucoma. * **Mydriasis without Cycloplegia:** Direct alpha-agonists (Phenylephrine/Epinephrine) cause mydriasis but spare the ciliary muscle (no loss of accommodation), unlike anticholinergics (Atropine).
Question 147: Retroperitoneal fibrosis is seen with which 5HT1 and 5HT2 receptor antagonist?
- A. Ketanserin
- B. Cyproheptadine
- C. Methysergide (Correct Answer)
- D. All of the above
Explanation: **Explanation:** **Methysergide** is a semi-synthetic ergot alkaloid that acts as a potent **5-HT2A/2C receptor antagonist**. Historically, it was used for the prophylaxis of migraine. However, its clinical use is now severely restricted due to a unique and serious adverse effect: **proliferative fibrotic complications**. The most characteristic of these is **retroperitoneal fibrosis** (Ormond’s disease), which can lead to ureteral obstruction and hydronephrosis. It can also cause pleuropulmonary fibrosis and endocardial fibrosis (valvular heart disease). The mechanism is thought to involve the agonist activity of its metabolite (methylergometrine) at 5-HT2B receptors, which triggers fibroblast proliferation. **Analysis of Incorrect Options:** * **Ketanserin:** A selective 5-HT2 receptor antagonist that also possesses alpha-1 blocking properties. It is primarily used as an antihypertensive and does not cause fibrotic complications. * **Cyproheptadine:** A combined 5-HT2 antagonist and H1-antihistamine. It is commonly used for allergic rhinitis, appetite stimulation, and managing Serotonin Syndrome. It is not associated with fibrosis. **High-Yield Clinical Pearls for NEET-PG:** * **Drug-Induced Fibrosis:** Methysergide is the "classic" drug associated with retroperitoneal fibrosis. Other drugs include **Bromocriptine** and **Ergotamine**. * **Drug Holiday:** To minimize the risk of fibrosis, Methysergide requires a "drug holiday" (stopping the drug for 3–4 weeks every 6 months). * **5-HT2B Connection:** Drugs that stimulate **5-HT2B receptors** (like Fenfluramine or Methysergide metabolites) are notorious for causing valvular and peritoneal fibrosis.
Question 148: Which toxin increases the exocytosis of acetylcholine-containing vesicles?
- A. Botulinum toxin
- B. Tetrodotoxin
- C. Saxitoxin
- D. Black widow spider toxin (Correct Answer)
Explanation: **Explanation:** The correct answer is **Black widow spider toxin (α-latrotoxin)**. **1. Mechanism of the Correct Answer:** α-latrotoxin acts by binding to presynaptic receptors (neurexins and latrophilins), which triggers a massive, uncontrolled influx of calcium into the nerve terminal. This leads to the **explosive exocytosis** of acetylcholine (ACh) vesicles into the neuromuscular junction. Clinically, this results in severe muscle spasms, abdominal rigidity, and pain (latrodectism). **2. Why the Other Options are Incorrect:** * **Botulinum toxin:** This toxin **inhibits** ACh release. It proteolytically cleaves SNARE proteins (like synaptobrevin or SNAP-25), preventing the fusion of vesicles with the presynaptic membrane. This leads to flaccid paralysis. * **Tetrodotoxin (Pufferfish toxin):** This is a potent **sodium channel blocker**. It prevents the initiation and conduction of action potentials along the axon, thereby stopping neurotransmitter release indirectly, but it does not affect the exocytosis mechanism itself. * **Saxitoxin (Red tide/Shellfish toxin):** Similar to tetrodotoxin, it blocks **voltage-gated sodium channels**, preventing neuronal conduction. **3. High-Yield Clinical Pearls for NEET-PG:** * **Vesicle Release:** Remember "B" for **B**otulinum **B**locks release; "Black widow" **B**lows out (increases) release. * **SNARE Proteins:** Targeted by Botulinum and Tetanus toxins. Botulinum affects peripheral cholinergic neurons (flaccid paralysis); Tetanus affects central inhibitory neurons (GABA/Glycine), leading to spastic paralysis. * **Lambert-Eaton Syndrome:** An autoimmune condition where antibodies attack P/Q-type calcium channels, also resulting in decreased ACh release (differentiated from Myasthenia Gravis by the "incremental response" on EMG).
Question 149: Which of the following is the drug of choice for treating anaphylactic shock?
- A. Isoprenaline
- B. Adrenaline (Correct Answer)
- C. Noradrenaline
- D. Terbutaline
Explanation: **Explanation:** **Adrenaline (Epinephrine)** is the drug of choice for anaphylactic shock because it acts as a **physiological antagonist** to histamine and other inflammatory mediators. Its efficacy lies in its potent action on multiple adrenergic receptors: * **$\alpha_1$ action:** Causes vasoconstriction, which increases peripheral vascular resistance to combat hypotension and reduces mucosal edema (laryngeal edema). * **$\beta_1$ action:** Exerts positive inotropic and chronotropic effects, improving cardiac output. * **$\beta_2$ action:** Causes bronchodilation and, crucially, **stabilizes mast cells**, preventing further release of histamine and leukotrienes. **Why other options are incorrect:** * **Isoprenaline:** A pure $\beta$-agonist ($\beta_1 + \beta_2$). While it causes bronchodilation, its potent $\beta_2$ vasodilatory effect can worsen hypotension, making it dangerous in shock. * **Noradrenaline:** Primarily an $\alpha$-agonist with some $\beta_1$ action. It lacks the $\beta_2$ activity required for bronchodilation and mast cell stabilization. * **Terbutaline:** A selective $\beta_2$ agonist. While it helps with bronchospasm, it does not provide the necessary $\alpha_1$ vasoconstriction to treat systemic hypotension or laryngeal edema. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Choice:** **Intramuscular (IM)** in the anterolateral thigh (vastus lateralis) is preferred over SC or IV in an emergency due to faster and more reliable absorption. * **Concentration:** Use **1:1000** for IM and **1:10,000** for IV (reserved for cardiac arrest or severe refractory shock). * **Standard Adult Dose:** 0.5 mg (0.5 ml of 1:1000 solution). * **Drug of Choice for other conditions:** Adrenaline is also the DOC for Cardiac Arrest and Glaucoma (Dipivefrine prodrug).
Question 150: A patient requires mild cholinomimetic stimulation following surgery. Physostigmine and bethanechol in small doses have significantly different effects on which of the following?
- A. Gastric secretion
- B. Neuromuscular junction (Correct Answer)
- C. Sweat glands
- D. Ureteral tone
Explanation: ### Explanation The core difference between **Physostigmine** and **Bethanechol** lies in their mechanism of action and the types of receptors they can ultimately stimulate. **1. Why Neuromuscular Junction (NMJ) is correct:** * **Physostigmine** is an **indirect-acting** cholinomimetic (acetylcholinesterase inhibitor). By inhibiting the enzyme that breaks down acetylcholine (ACh), it increases ACh levels at **both** muscarinic and **nicotinic** receptors. Since the NMJ contains nicotinic receptors ($N_M$), physostigmine has a significant effect there (potentially causing fasciculations or increasing muscle strength). * **Bethanechol** is a **direct-acting** cholinomimetic that is highly selective for **muscarinic receptors**. It has virtually **no effect** on nicotinic receptors at the NMJ. Therefore, the difference in their effect on skeletal muscle is profound. **2. Why other options are incorrect:** * **Gastric secretion, Sweat glands, and Ureteral tone:** These functions are all mediated by **muscarinic receptors** ($M_1$, $M_3$). Both drugs—physostigmine (via increased endogenous ACh) and bethanechol (via direct stimulation)—will activate these receptors. Consequently, both drugs will increase gastric acid, sweating, and ureteral contraction in a similar manner. **3. NEET-PG High-Yield Pearls:** * **Bethanechol:** Used clinically for post-operative urinary retention and paralytic ileus ("**B**ethanechol for the **B**ladder and **B**owel"). * **Physostigmine:** A tertiary amine that **crosses the Blood-Brain Barrier (BBB)**. It is the drug of choice for **Atropine poisoning**. * **Neostigmine:** Unlike physostigmine, it is a quaternary ammonium compound (does not cross BBB) and is used for Myasthenia Gravis and reversing NMJ blockade. * **Mnemonic:** **P**hysostigmine **P**enetrates the CNS; **N**eostigmine **N**o CNS entry.
Practice by Chapter
Cholinergic Agonists
Practice Questions
Cholinergic Antagonists
Practice Questions
Adrenergic Agonists
Practice Questions
Adrenergic Antagonists
Practice Questions
Ganglionic Agents
Practice Questions
Neuromuscular Blocking Agents
Practice Questions
Autonomic Drugs in Ophthalmology
Practice Questions
Autonomic Drugs in Cardiovascular Disease
Practice Questions
Autonomic Drugs in Respiratory Disease
Practice Questions
Autonomic Drugs in Urological Disorders
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free